Related Experiment Video
Updated: Nov 4, 2025

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Identifying clinical practice guidelines for symptom control in pediatric oncology
Paula D Robinson1, Deborah Tomlinson2, Melissa Beauchemin3
1Pediatric Oncology Group of Ontario, 1014 - 480 University Avenue, Toronto, ON, M5G 1V2, Canada.
A new process identified clinical practice guidelines (CPGs) for managing 14 of 15 distressing symptoms in pediatric cancer patients. This systematic approach aids in improving cancer symptom management for children and adolescents.
Area of Science:
- Pediatric Oncology
- Clinical Practice Guidelines
- Symptom Management
Background:
- Pediatric cancer patients frequently experience severe symptoms like pain and nausea.
- Clinical practice guideline-consistent care is linked to improved patient outcomes.
- A systematic process is needed to identify applicable symptom management guidelines for this population.
Purpose of the Study:
- To develop and implement a tiered process for identifying clinical practice guidelines (CPGs) for symptom management in pediatric cancer patients.
- To ensure comprehensive coverage of 15 key symptoms relevant to this patient group.
Main Methods:
- A three-tiered approach was used to identify CPGs: Tier 1 (Children's Oncology Group endorsed), Tier 2 (specific reputable repositories/organizations), and Tier 3 (systematic review).
- Searches prioritized guidelines published between 2015-2020, with a fallback to 2010-2014 if needed.
- The process was applied to 15 common symptoms experienced by children with cancer.
Main Results:
- CPGs were identified for 14 out of 15 symptoms using the defined process.
- Six Tier 1 and 13 Tier 2 CPGs were found for the 2015-2020 period.
- A systematic review (Tier 3) was necessary for four symptoms, yielding CPGs for pain but not for anger.
Conclusions:
- A structured process successfully identified relevant clinical practice guidelines for most (14/15) pediatric cancer symptoms.
- The developed process is effective in locating supportive care CPGs for pediatric oncology.
- Future research should concentrate on implementing these CPGs and assessing their impact on patient and provider outcomes.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
